Literature DB >> 23988025

Crocetin attenuates spatial learning dysfunction and hippocampal injury in a model of vascular dementia.

Faezeh Tashakori-Sabzevar1, Hossein Hosseinzadeh, Vahideh Sadat Motamedshariaty, Ahmad Reza Movassaghi, Seyed Ahmad Mohajeri.   

Abstract

Chronic cerebral hypoperfusion produces brain ischemia and is associated with related memory impairment. In this study, we prepared crocetin from crocin (the main water soluble pigment in saffron stigmas) in an acidic hydrolysis and its purity was evaluated using spectrophotometry, thin layer chromatography (TLC) and high performance liquid chromatography (HPLC). The memory enhancing effect of crocetin was then studied in a rat model of chronic cerebral hypoperfusion. Different doses of crocetin were administered intraperitoneally (i.p.). The spatial learning and memory function were tested using Morris water maze, after permanent occlusion of common carotids. Finally, the animals were euthanatized in CO2 chamber and histopathological changes in cerebral cortex and hippocampus were investigated. The results indicated that the escape latency time significantly decreased in crocetin treated rats, in comparison with control animals. Also, the percentage of time spent and traveled distance in target quadrant on final test trial day increased in crocetin 8 mg/kg group, compared to control group, while no difference was observed between groups in swimming speed. All behavioral results were confirmed by histopathological analysis. According to our data, crocetin (8 mg/kg) could properly protect cerebrocortical and hippocampus neurons against ischemia. In conclusion, treatment with crocetin could effectively prevent neuropathological alterations in hippocampus thereby resulting in improvement of spatial learning memory in rats after chronic cerebral hypoperfusion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23988025     DOI: 10.2174/15672026113109990032

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  7 in total

Review 1.  HDL and cognition in neurodegenerative disorders.

Authors:  David A Hottman; Dustin Chernick; Shaowu Cheng; Zhe Wang; Ling Li
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

Review 2.  Avicenna's pharmacological approach to memory enhancement.

Authors:  Roja Rahimi; Shahrzad Irannejad; Maryam Noroozian
Journal:  Neurol Sci       Date:  2017-02-07       Impact factor: 3.307

Review 3.  Therapeutic effects of saffron (Crocus sativus L.) in digestive disorders: a review.

Authors:  Alireza Rezaee Khorasany; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2016-05       Impact factor: 2.699

Review 4.  Crocetin: A Systematic Review.

Authors:  Zi-Liang Guo; Mao-Xing Li; Xiao-Lin Li; Peng Wang; Wei-Gang Wang; Wei-Ze Du; Zhi-Qiang Yang; Sheng-Fu Chen; Di Wu; Xiu-Yu Tian
Journal:  Front Pharmacol       Date:  2022-01-14       Impact factor: 5.810

5.  Crocetin attenuates inflammation and amyloid-β accumulation in APPsw transgenic mice.

Authors:  Jin Zhang; Yuchao Wang; Xueshuang Dong; Jianghua Liu
Journal:  Immun Ageing       Date:  2018-10-30       Impact factor: 6.400

6.  Protective Effects of Crocetin on Arsenic Trioxide-Induced Hepatic Injury: Involvement of Suppression in Oxidative Stress and Inflammation Through Activation of Nrf2 Signaling Pathway in Rats.

Authors:  Yanshuang Liu; Yingran Liang; Bin Zheng; Li Chu; Donglai Ma; Hongfang Wang; Xi Chu; Jianping Zhang
Journal:  Drug Des Devel Ther       Date:  2020-05-19       Impact factor: 4.162

7.  Crocetin alleviates myocardial ischemia/reperfusion injury by regulating inflammation and the unfolded protein response.

Authors:  Ming Yang; Genxiang Mao; Lili Ouyang; Chenhui Shi; Pengfei Hu; Shuwei Huang
Journal:  Mol Med Rep       Date:  2019-12-17       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.